Molecular Characterization of Cutaneous Tumors

April 28, 2019 updated by: Rabin Medical Center
The objective is to find genes which are responsible for the appearance of skin tumors (sCC, BCC) and it will be the basis for prediction of the disease and response to the treatment

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

Prospective, 1-arm, 500 participates above 18 age with skin tumor affliction sCC and BCC type.

Study Type

Observational

Enrollment (Anticipated)

500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: DR Asaf Olshinka, MD
  • Phone Number: +972-3-9376366

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

above 18 years old with Scc and BCC skin tumors not pregnant women and no children or any person without judgment ability

Description

Inclusion Criteria:

  • patient that have sCC and BCC tumors
  • above 18 years old

Exclusion Criteria:

  • below 18 years old
  • pregnant women
  • children or person without judgment ability

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
1-arm, 500 participates
Molecular testing of DNA/RNA from skin tumors, SCC/BCC
Genetic: Molecular testing of DNA/RNA from skin tumors, SCC/BCC
Molecular testing of DNA/RNA from skin tumors, SCC/BCC

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Molecular Characterization of cutaneous tumors
Time Frame: 5 years
samples from subjects
5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Rabin Medical Center

Investigators

  • Principal Investigator: DR Dean Ad EL, MD, Rabin Medical Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 29, 2017

Primary Completion (Anticipated)

August 7, 2020

Study Completion (Anticipated)

August 7, 2020

Study Registration Dates

First Submitted

March 22, 2017

First Submitted That Met QC Criteria

March 27, 2017

First Posted (Actual)

March 28, 2017

Study Record Updates

Last Update Posted (Actual)

April 30, 2019

Last Update Submitted That Met QC Criteria

April 28, 2019

Last Verified

April 1, 2019

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 0515-15-RMC

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Basal Cell Carcinoma

Clinical Trials on Molecular testing of DNA/RNA from skin tumors, SCC/BCC

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tanzania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe